Curaleaf (OTCMKTS:CURLF) Stock Price Up 4.8% – Here’s What Happened

Curaleaf Holdings, Inc. (OTCMKTS:CURLF)’s share price shot up 4.8% during trading on Friday . The company traded as high as $9.81 and last traded at $9.81. Approximately 127,836 shares traded hands during trading, a decline of 58% from the average daily volume of 301,936 shares. The stock had previously closed at $9.36.

Analyst Ratings Changes

CURLF has been the topic of several recent analyst reports. Citigroup reiterated a “buy” rating on shares of Curaleaf in a report on Thursday, August 6th. Zacks Research upgraded shares of Curaleaf from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 14th. Three equities research analysts have rated the stock with a Strong Buy rating and two have given a Buy rating to the stock. According to MarketBeat.com, Curaleaf has an average rating of “Strong Buy”.

Curaleaf Stock Up 4.8%

The company has a quick ratio of 0.73, a current ratio of 1.52 and a debt-to-equity ratio of 1.06. The company’s fifty day simple moving average is $8.10 and its 200 day simple moving average is $7.94. The firm has a market capitalization of $2.29 billion, a PE ratio of -75.45 and a beta of 1.56.

Curaleaf (OTCMKTS:CURLF) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of ($0.20) by $0.25. Curaleaf had a negative return on equity of 0.88% and a negative net margin of 2.62%.The business had revenue of $340.10 million for the quarter, compared to analysts’ expectations of $332.00 million. Analysts anticipate that Curaleaf Holdings, Inc. will post 0.01 earnings per share for the current fiscal year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.